Search Results - "Kruczynski, Kate L"

Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution by Pisanic, Nora, Antar, Annukka A R, Hetrich, Marissa K, Demko, Zoe O, Zhang, Xueyan, Spicer, Kristoffer, Kruczynski, Kate L, Detrick, Barbara, Clarke, William, Knoll, Maria Deloria, Thomas, David L, Dawood, Fatimah S, Veguilla, Vic, Karron, Ruth A, Manabe, Yukari C, Heaney, Christopher D

“…Abstract Background Efforts are underway to support the development of novel mucosal coronavirus disease 2019 (COVID-19) vaccines. However, there is limited…”
Get full text

Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses by Pisanic, Nora, Antar, Annukka A.R., Kruczynski, Kate L., Gregory Rivera, Magdielis, Dhakal, Santosh, Spicer, Kristoffer, Randad, Pranay R., Pekosz, Andrew, Klein, Sabra L., Betenbaugh, Michael J., Detrick, Barbara, Clarke, William, Thomas, David L., Manabe, Yukari C., Heaney, Christopher D.

“…Oral fluid (hereafter, saliva) is a non-invasive and attractive alternative to blood for SARS-CoV-2 IgG testing; however, the heterogeneity of saliva as a…”
Get full text

Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution by Pisanic, Nora, Antar, Annukka A R, Hetrich, Marissa K, Demko, Zoe O, Zhang, Xueyan, Spicer, Kristoffer, Kruczynski, Kate L, Detrick, Barbara, Clarke, William, Knoll, Maria Deloria, Thomas, David L, Dawood, Fatimah S, Veguilla, Vic, Karron, Ruth A, Manabe, Yukari C, Heaney, Christopher D

“…High priority efforts are underway to support the development of novel mucosal COVID-19 vaccines, such as the US Government's Project NextGen and the Center…”
Get full text